Zacks Investment Research upgraded shares of ON ASSIGNMENT (ASGN) from UNDERPERFORM to NEUTRAL on May 01, 2013, with a target price of $24.90.
On Assignment, Inc., through its first operating division, Lab Support, is a leading nationwide provider of temporary scientific professionals to laboratories in the biotechnology, pharmaceutical, food and beverage, chemical, and environmental industries. The company's strategy is to serve the needs of targeted industries for quality assignments of temporary professionals.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ON ASSIGNMENT (ASGN),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment